These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine. Kenyon RH; Kishimoto RA; Hall WC Infect Immun; 1979 Aug; 25(2):580-2. PubMed ID: 114488 [TBL] [Abstract][Full Text] [Related]
24. Spotted fever vaccine; potency assay by direct challenge of vaccinated mice with toxin of Rickettsia rickettsii. BELL EJ; STOENNER HG J Immunol; 1961 Dec; 87():737-46. PubMed ID: 13866804 [No Abstract] [Full Text] [Related]
25. Protection of guinea pigs from experimental Rocky Mountain spotted fever with a cloned antigen of Rickettsia rickettsii. McDonald GA; Anacker RL; Mann RE; Milch LJ J Infect Dis; 1988 Jul; 158(1):228-31. PubMed ID: 3134494 [No Abstract] [Full Text] [Related]
26. Genomic comparison of virulent Rickettsia rickettsii Sheila Smith and avirulent Rickettsia rickettsii Iowa. Ellison DW; Clark TR; Sturdevant DE; Virtaneva K; Porcella SF; Hackstadt T Infect Immun; 2008 Feb; 76(2):542-50. PubMed ID: 18025092 [TBL] [Abstract][Full Text] [Related]
27. Protection of guinea-pigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA protein. Sumner JW; Sims KG; Jones DC; Anderson BE Vaccine; 1995 Jan; 13(1):29-35. PubMed ID: 7762273 [TBL] [Abstract][Full Text] [Related]
28. Suppression of cellular immune responses in guinea pigs infected with spotted fever group rickettsiae. Oster CN; Kenyon RH; Pedersen CE Infect Immun; 1978 Nov; 22(2):411-7. PubMed ID: 730362 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of a killed Rocky Mountain spotted fever vaccine in cynomolgus monkeys. Gonder JC; Kenyon RH; Pedersen CE J Clin Microbiol; 1979 Nov; 10(5):719-23. PubMed ID: 120877 [TBL] [Abstract][Full Text] [Related]
30. Rhipicephalus sanguineus: vector of a new spotted fever group rickettsia in the United States. Burgdorfer W; Sexton DJ; Gerloff RK; Anacker RL; Philip RN; Thomas LA Infect Immun; 1975 Jul; 12(1):205-10. PubMed ID: 806533 [TBL] [Abstract][Full Text] [Related]
31. Enhanced protection against Rickettsia rickettsii infection in C3H/HeN mice by immunization with a combination of a recombinant adhesin rAdr2 and a protein fragment rOmpB-4 derived from outer membrane protein B. Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B Vaccine; 2015 Feb; 33(8):985-92. PubMed ID: 25597943 [TBL] [Abstract][Full Text] [Related]
32. Cross-reaction of immune sera from patients with rickettsial diseases. Hechemy KE; Raoult D; Fox J; Han Y; Elliott LB; Rawlings J J Med Microbiol; 1989 Jul; 29(3):199-202. PubMed ID: 2501497 [TBL] [Abstract][Full Text] [Related]
33. The isolation of strains of rickettsiae of the spotted fever group in Israel and their differentiation from other members of the group by immunofluorescence methods. Goldwasser RA; Steiman Y; Klingberg W; Swartz TA; Klingberg MA Scand J Infect Dis; 1974; 6(1):53-62. PubMed ID: 4208205 [No Abstract] [Full Text] [Related]
34. Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. Breitschwerdt EB; Papich MG; Hegarty BC; Gilger B; Hancock SI; Davidson MG Antimicrob Agents Chemother; 1999 Apr; 43(4):813-21. PubMed ID: 10103185 [TBL] [Abstract][Full Text] [Related]